Cannabidiol (CBD) is a chemical compound produced by plants in the cannabis family. Since most of the CBD on the American market is extracted from hemp, a nonpsychoactive form of cannabis, cannabidiol will not intoxicate you. For the past couple of years, people have been turning to this hemp extract as an alternative medicine for a variety of health problems. Studies have shown that it can be effective at alleviating the symptoms of medical conditions such as chronic pain, anxiety depression and insomnia.
Furthermore, the FDA has approved a CBD-based drug called Epidiolex to treat two rare forms of pediatric epilepsy: Dravet syndrome and Lennox-Gastaut syndrome.
Experts have cautioned the public against seeing CBD as a miracle cure that can treat any condition, stating the hype around CBD treatments seems to have eclipsed the science. There is limited research on cannabidiol, and we still don’t know much about its potential benefits and risks, especially over the long term.
This problem becomes even more serious when you consider the fact that there are companies making CBD products for children with barely any regulation from the federal government. And according to a new report from the University of Michigan’s C.S. Mott Children’s Hospital, some parents are willing to give their children CBD.
Researchers surveyed 2,020 parents with at least one child aged one to eighteen years old. They discovered that three in four parents were receptive to the idea of giving their children CBD if other medications were not effective. Sarah Clark, the poll’s codirector, says the results point to parents being more open-minded about CBD treatments.
However, the report noted that most parents do not have access to crucial information about CBD. One-third of the respondents didn’t know that CBD was nonpsychoactive and believed that using the cannabinoid is no different from using marijuana. Such parents would be more likely to prevent their children from using CBD even when they could benefit
Clark believes that parents who don’t understand the difference between CBD and THC (the main psychoactive agent in cannabis) can be properly educated via continued exposure and explanation. On the other hand, she is optimistic that the respondents who expressed that they would give their children CBD if other medications did not work at least have a basic understanding of the cannabinoid. Those parents realize that there is no miracle medicine that can cure every childhood ailment, she says.
The poll also revealed that 83% of parents believed the FDA should regulate CBD products meant for children, and 74% feel that you should have a doctor’s prescription before you can give CBD to your children.
With such a willingness to give CBD to kids, parents could soon take to the cutting-edge cannabis cultivation “micro-farms” made and marketed by entities such as Advanced Container Technologies Inc. (OTC: ACTX) as these companies seek to take matters into their own hands while federal regulators consider ways to regulate this nonintoxicating cannabinoid.
NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Do you have questions or are you interested in working with CNW420? Ask our Editor
CNW420 is part of the InvestorBrandNetwork.